Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
+13.96%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$4.74B
AUM Growth
-$4.89B
Cap. Flow
-$250M
Cap. Flow %
-5.27%
Top 10 Hldgs %
49.5%
Holding
1,224
New
10
Increased
9
Reduced
12
Closed
13

Sector Composition

1 Real Estate 58.35%
2 Technology 5.66%
3 Healthcare 4.64%
4 Consumer Discretionary 4.34%
5 Communication Services 4.06%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MNTA
1001
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$18K ﹤0.01%
653
ARGX icon
1002
argenx
ARGX
$47B
$17K ﹤0.01%
129
FGEN icon
1003
FibroGen
FGEN
$45.1M
$17K ﹤0.01%
20
PRDO icon
1004
Perdoceo Education
PRDO
$2.18B
$17K ﹤0.01%
1,530
GBT
1005
DELISTED
Global Blood Therapeutics, Inc.
GBT
$17K ﹤0.01%
340
ARWR icon
1006
Arrowhead Research
ARWR
$3.76B
$16K ﹤0.01%
566
PR icon
1007
Permian Resources
PR
$9.69B
$16K ﹤0.01%
59,480
PTCT icon
1008
PTC Therapeutics
PTCT
$4.52B
$16K ﹤0.01%
348
IMMU
1009
DELISTED
Immunomedics Inc
IMMU
$16K ﹤0.01%
1,190
MEDP icon
1010
Medpace
MEDP
$13.8B
$15K ﹤0.01%
203
GWPH
1011
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$15K ﹤0.01%
166
AGIO icon
1012
Agios Pharmaceuticals
AGIO
$2.12B
$14K ﹤0.01%
386
BLUE
1013
DELISTED
bluebird bio
BLUE
$14K ﹤0.01%
24
EWW icon
1014
iShares MSCI Mexico ETF
EWW
$1.85B
$14K ﹤0.01%
500
GRFS icon
1015
Grifois
GRFS
$6.88B
$14K ﹤0.01%
711
HALO icon
1016
Halozyme
HALO
$8.76B
$14K ﹤0.01%
769
RARE icon
1017
Ultragenyx Pharmaceutical
RARE
$3.04B
$14K ﹤0.01%
326
ALLO icon
1018
Allogene Therapeutics
ALLO
$253M
$13K ﹤0.01%
688
BRT
1019
BRT Apartments
BRT
$283M
$13K ﹤0.01%
1,300
FOLD icon
1020
Amicus Therapeutics
FOLD
$2.46B
$13K ﹤0.01%
1,438
ZLAB icon
1021
Zai Lab
ZLAB
$3.49B
$13K ﹤0.01%
250
CCXI
1022
DELISTED
ChemoCentryx, Inc.
CCXI
$13K ﹤0.01%
329
ALLK
1023
DELISTED
Allakos
ALLK
$12K ﹤0.01%
275
KOD icon
1024
Kodiak Sciences
KOD
$517M
$12K ﹤0.01%
246
TLK icon
1025
Telkom Indonesia
TLK
$19B
$12K ﹤0.01%
630